Business Standard

Aurobindo Pharma Glenmark Pharmaceuticals

Aurobindo terminates $900-million Sandoz product acquistion deal

A mutual decision to cancel the agreement was taken as approval from US Federal Trade Commission was not obtained within anticipated timelines

Aurobindo terminates $900-million Sandoz product acquistion deal
Updated On : 02 Apr 2020 | 8:23 PM IST

Glenmark and Lupin: Are pharma stocks a good contrarian bet?

Glenmark Pharma is continuously going down from Rs 600 levels and is not showing any sign of recovery.

Glenmark and Lupin: Are pharma stocks a good contrarian bet?
Updated On : 17 Oct 2019 | 12:57 PM IST

Lakshmi Vilas Bank, IndusInd Bank & 32 other BSE500 stocks hit 52-wk low

Aurobindo Pharmaceuticals, BHEL, Ambuja Cements, Grasim Industries, Zee Entertainment, Glenmark Pharmaceuticals, Lupin and LIC Housing Finance were among the 34 stocks that hit their 52-week lows

Lakshmi Vilas Bank, IndusInd Bank & 32 other BSE500 stocks hit 52-wk low
Updated On : 07 Oct 2019 | 2:20 PM IST

Aurobindo Pharma, Glenmark Pharma hit 52-week highs

Aurobindo Pharma was up 9% at Rs 826, surging 22% in past three trading days after the company on Thursday announced the acquisition of Sandoz's generic business in the US for $900 million.

Aurobindo Pharma, Glenmark Pharma hit 52-week highs
Updated On : 07 Sep 2018 | 12:43 PM IST